ERBB2 and breast cancer: Collectively, these findings suggest that the PI3K/AKT/mTOR, MAPK, and collagen-related pathways play a particularly prominent role in the aggressive behavior of TNBC and Non-luminal HER2+ breast cancer subtypes.